Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07256977Not ApplicableNot Yet Recruiting

Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical Cancer

Role: collaborator

NCT06850376Not ApplicableCompleted

COVID Feel Good-An Easy Self-Help Virtual Reality Protocol to Overcome the Psychological Burden of Coronavirus

Role: collaborator

NCT02707575Completed

Cytokeratin 8 Level in Age-related Macular Degeneration

Role: collaborator

NCT03607851Phase 4Completed

Efficacy and Safety of Rapid Titration Protocols of Lacosamide

Role: collaborator

NCT03041818Not ApplicableCompleted

Development of Horse-Riding Program Model for Children With Cerebral Palsy

Role: collaborator

NCT00988676Completed

The Effect of Bowel Preparation Status on the Polyp Missing Rate

Role: collaborator

All 6 trials loaded